COVID-19 Research

NECAT is giving priority to COVID-19 research while accepting all GUP beamtime requests.

COVID-19 Research

Novel Coronavirus

On June 15, 2020, Argonne and the Advanced Photon Source started a phased, coordinated process to return to normal operations. The first phase of the transition is from minimum safe operations – the state APS was in starting March 21 – to a stage known as limited operations.

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite.

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class.

Advances in COVID-19 Prevention and Treatment Enabled by Structural Biology Research

The emergence of the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) -- the etiologic agent responsible for the current outbreak of COVID-19 -- mobilized research communities around the world to investigate the virus and the disease at unprecedented speed. To deliver information suitable for the development of vaccines, therapeutics, and diagnostics, researchers representing multiple disciplines and institutions quickly initiated broad collaborations, while DOE user facilities provided unlimited access to resources necessary for this research.

Office Hours

Questions?

....Answers Provided.

 

Zoom-based office hours to answer questions regarding using NE-CAT, data processing, structure solution or anything else x-ray crystallography-related available weekly.

Thursday, 1:00 - 3:00 PM Central Time

Request the Zoom link via email.

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms.

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design.

Pages